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1. Introduction 
The role of glucoco~icoids in the regulation of 
hepatic glucose production by metabolic processes 
such as glycogenolysis and gluconeogenesis has been 
termed ‘permissive’ since they are essential for the 
maintenance of normal responsiveness of cells to 
hormones which act through cyclic AMP [ 11. In iso- 
lated perfused livers from adrenalectomised rats 
maximal concentrations of glucagon activate phos- 
phorylase normally but physiological concentrations 
do not [2,3]. Further, a lack of adrenal corticoste- 
roids caused a significant reduction in total phos- 
phorylase activity with no change in the level of 
active phosphorylase [4]. Glucagon-stimulated cyclic 
AMP accumulation by livers perfused in vitro has 
been reported as normal or increased [2]. Several 
laboratories have reported no change in cyclic AMP- 
dependent protein kinase activity in liver homage. 
nates obtained from normal or adrenalectomised rats 
[5,6], but others have found only 75% of the normal 
activity of type I cyclic ASP-dependent protein 
kinase in liver homogenates obtained from adrenal- 
ectomised rats [7]. 
Thus, despite extensive investigation, the mecha- 
nisms by which glucocorticoids participate in the 
regulation of hepatic glycogen metabolism have yet 
to be clearly defined. This is due in part to the use 
of adrenale~tomised animals for such studies and the 
attendant problem of hormone interaction inherent 
in such an in vivo system. Ilepatocytes in primary 
monolayer culture are viable for several days in a 
totally defined en~ronment [S-IO] and as such 
should provide a useful system in which to study 
glucocorticoid effects on glycogen metabolism. 
Therefore, a study of the enzymes of hepatic gly- 
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cogen metabolism was undertaken in hepatocytes 
maintained in primary monolayer culture in the pre- 
sence and absence of a biologically active synthetic 
glucocorticoid, dexamethasone. 
2, Materials and methods 
Isolated hepatocytes were made by in vitro perfu- 
sion of liver [ 1 I ] from male rats of a random-bred 
Wistar strain (180-200 g>. The isolated hepatocytes 
were suspended at 2 X lo6 cells/ml in Leibovitz-15 
tissue culture medium (L-15) supplemented with 
25 mM Hepes, 20 mM glucose, 100 units penicillin~ml 
and 10% foetal calf serum. Aliquots of the cell sus- 
pension (2.5 ml) were innoculated onto 60 mm diam. 
tissue culture dishes (Falcon plastics, Calif.) and 
incubated at 37°C in humidi~ed air. After 6 h the 
medium was removed and exchanged for serum-free 
L”l5 with or without 1 PM dexamethasone. After 
24 h in vitro the culture medium was aspirated, the 
cells washed and suspended in an appropriate buffer, 
and homogenised by 20 strokes of an A pestle in a 
Dounce homogeniser. 
The activities of the following enzymes were 
measured directly on the homogenate by standard 
methods: glycogen synthase [12], phosphorylase a 
[ 131, total phosphorylase after in vitro activation 
with muscle phosphorylase kinase ]14], total phos- 
phorylase b kinase [15], protein kinase [16] and 
cyclic AMP phosphodiesterase [ 171. Phosphorylase 
phosphatase activity was measured by the rate of 
inactivation of pllosphorylase a. Hepatocyte cultures 
were preincubated with glucagon for 5 min to elevate 
phosphorylase a. The cultures were homogenised 
and incubated at 30°C in 25 mM MES (pH 6.8), 
165 
Volume 119, number 1 
5 mM EDTA, 45 mM mercaptoethanol, which pre- 
vents the conversion of phosphorylase a to b, but 
allows expression of phosphatase activity. At 2 min 
intervals, aliquots were diluted in 50 mM MES 
(pH 6.1), 200 mM NaF, 10 mM EDTA. 45 mM 
mercaptoethanol and 50 1.11 of the mixture assayed 
for phosphorylase a [ 131. The phosphorylase a activ- 
ity plotted against time approximated first-order 
kinetics. Since endogenous phosphorylase a was the 
substrate and since it was not possible to measure the 
initial reaction velocrty, results are expressed as a 
first-order rate constant for the reaction rather than 
in conventional enzyme units. Protein [ 181, cyclic 
AMP [19] and glycogen [20] were measured by 
standard techniques. 
3. Results and discussion 
The hepatocyte cultures synthesised glycogen 
from glucose present in the culture medium (table 1) 
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Table 1 
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Glycogen content of hepatocytes cultured in the presence 
or absence of 1 nM dexamethasone for 24 and 48 h 
24 h 48 h 
_ + + 
Glycogen 10.43” 4.43 26.519~ 10.63 
(fig glycogen/mg *2.30 +0.95 +3.90 +1.31 
protein) (8) (8) (11) (11) 
a P < 0.01 for dexamethasone-treated cells compared to 
control cells; P-values were calculated using Student’s t-test 
for paired variates 
as reported [8,9,10]. However, in contrast to reports 
that the level of glycogen declined over a 3-day cul- 
ture period [10,21] the concentration of glycogen 
doubled between 24 and 48 h in vitro. Hepatocytes 
cultured in the presence of dexamethasone had less 
glycogen at both 24 and 48 h than cells cultured in 
the absence of this glucocorticoid. This is in contrast 
Table 2 
Enzyme activities and cyclic AMP concentration of hepatocytes cultured in the presence or 
absence of 1 PM dexamethasone for 24 h 
Dexamethasone 
- t 
Total glycogen synthase 
(nmol min-’ mg protein’) 
Active glycogen synthase 
(nmol . mm-‘. mg protein-‘) 
Total phosphorylase 
(nmol mm-‘. mg protein-‘) 
Phosphorylase a 
(nmol . mm-‘. mg protein“) 
Phosphorylase phosphatase 
(s-1) 
Total phosphorylase kinase 
tmU phosphorylase a mm-‘. mg protein-‘) 28.25 + 7.80 (8) 27.63 ? 8.43 (8) 
Total protein kinase 
(nmol mine’. mg protein-‘) 57.6 * 1.9 (7) 58.6 i 7.7 (7) 
Cyclic AMP 
(pm01 . mg protein-‘) 1.00 * 0.11 (5)a 1.64 * 0.11 (5) 
Low Km cyclic AMP phosphodiesterase 
(pm01 mm-‘. mg protein-‘) 8.84 + 0.66 (5)a 8.04 f 0.84 (5) 
High Km CAMP phosphodiesterase 
(pm01 min“. mg protein-‘) 1421 + 142 (5) 1370 + 161 (5) 
4.18 ? 0.58 (6) 3.95 * 0.48 (6) 
0.47 * 0.06 (6) 0.42 * 0.05 (6) 
93.03 t- 17.78 (9) 93.89 t 17.39 (9) 
12.75 * 1.31 (8) 31.7 + 4.4 (8) 
0.05 f 0.01 (5) 0.05 + 0.01 (5) 
a P < 0.01; P-values were calculated using Student’s r-test for paired variates 
A milliunit of enzyme activity is that amount of enzyme that incorporated 1 nmol [“‘C]G-1-P 
into glycogen/min under the conditions of the assay 
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to in vivo studies where liver glycogen was decreased 
by adrenalectomy then slowly increased by gluco- 
corticoid administration [22,23]. However, using a 
different synthetic glucocorticoid (betamethasone 
dipropionate) glucocorticoid suppression of glycogen 
accumulation was observed in foetal rat liver [24]. 
The presence of dexamethasone in the culture 
medium had no effect on total glycogen synthase 
activity and the amount of enzyme in the active form 
(table 2). If it is assumed that glycogen synthase is 
the rate-limiting enzyme for glycogen synthesis, then 
the differences in glycogen content must be due to 
an increased mobilisation and therefore be reflected 
in one or more of the enzymes responsible for gly- 
cogen degradation. It was found that dexamethasone 
produced a 2-fold increase in phosphorylase a activity 
with no increase in total phosphorylase. This is simi- 
lar to the observation that phosphorylase a in foetal 
rat liver was increased after treatment with gluco- 
corticoid for 24 h [24]. Hepatocytes isolated from 
adrenalectomised rats are reported to have decreased 
activities of both total and active phosphorylase com- 
pared to hepatocytes from normal rats [25]. 
The increase in active phosphorylase could be due 
to a decrease in activity of phosphorylase phospha- 
tase or an increase in activity of phosphorylase b 
kinase. However, the activities of phosphorylase phos- 
phatase and phosphorylase b kinase were unaffected 
by culture of the hepatocytes in the presence of 
dexamethasone (table 2). Dexamethasone also had no 
effect on total cyclic AMP-dependent protein kinase 
activity. Due to the low total protein kinase activity 
phosphodiesterase (table 2). There is conflict con- 
cerning the effect of glucocorticoids on hepatic phos- 
phodiesterase activity. Phosphodiesterase activity 
was unchanged following adrenalectomy [27] or on 
incubation of hepatoma tissue culture cells with 
dexamethasone [28]. Conversely, glucocorticoid 
administration decreased the activity of phospho- 
diesterase in several tissues [29] and in hepatoma 
tissue culture cells [30]. 
Incubation of hepatocyte cultures with dexa- 
methasone causes a lowering of the glycogen content 
of the cells. It appears to be due to an increase in 
mobilisation of glycogen associated with an activation 
of glycogen phosphorylase. The glucocorticoid also 
produces an elevation in tissue cyclic AMP which 
would indicate that the hormone is probably exerting 
its effects by activation of protein kinase and phos- 
phorylase b kinase. However, so far it has not been 
possible to demonstrate direct effects on these 
enzymes and an increase in phosphorylase a indepen- 
dent of changes in cyclic AMP concentration cannot 
be ruled out. 
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